Hydroxychloroquine Removed From FDA Emergency Use Authorization

Guided by their scientific findings, the FDA has removed Hydroxychloroquine and Chloroquine from the FDA emergency authorization citing “ineffectiveness”.

Once thought to be an effective treatment for Covid-19, scientist have found that the malaria fighting drugs “showed no benefit on mortality or in a speedy recovery” during clinical trials.

Acting director Patrizia Cavazzoni, M.D closed the announcement by reiterating that “We (FDA) remain committed to using every tool at our disposal in collaboration with innovators and researchers to provide sick patients timely access to appropriate new therapies. Our decisions will always be based on objective and rigorous evaluation of the scientific data. This will never change.”

Click on the link to read more: Coronavirus (COVID-19) Update: FDA Revokes Emergency Use Authorization for Chloroquine and Hydroxychloroquine | FDA